Current Funding Portfolio (ordered by start date) | Vanderbilt Institute for Global Health

NIH Grant Bolsters Childhood Status Epilepticus and Epilepsy Research in Nigeria

February 8, 2021

Vanderbilt Institute for Global Health (VIGH) has received a new research grant from the National Institute of Neurological Disorders and Stroke and Fogarty International Center of the NIH to establish a large childhood status epilepticus (SE) cohort in northern Nigeria with key partners Aminu Kano Teaching Hospital (AKTH) and Bayero University, and with the Sydney Brenner Institute for Molecular Bioscience at the University of the Witwatersrand (Wits) in South Africa.

Edwin Trevathan, Nigeria, Aminu Kano Teaching Hospital, Status Epilepticus, Epilepsy, Umar Sabo

Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH)

June 1, 2020

https://vumc.org/v-brch

The Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH) Program builds capacity of Nigerian investigators to successfully initiate and implement high-quality clinical trials in HIV-associated non-communicable diseases.

Muktar Aliyu, William Wester, Nigeria, HIV, Non-Communicable Diseases (NCDs)

PeerNaija: A Mobile Health Platform

September 26, 2019

The scale-up of global antiretroviral therapy (ART) represents an unparalleled global health success story, leading to impressive overall reductions in HIV-related morbidity and mortality. However, adolescents and young adults (AYA), especially those in Sub-Saharan Africa, have largely been left out of this story. While AIDS-related deaths declined by 30% for adults from 2005-2012, they increased by 50% among AYA over the same period, making AIDS the leading cause of death among African youth. AYA living with HIV perform poorly across the entire care continuum.

Aimalohi Ahonkhai, MHealth, Nigeria, HIV/AIDS